Результаты поиска - Michael T. Nurmohamed

Отмена результатов
  1. 1
    Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022

    Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022 по Bas Dijkshoorn, Reinder Raadsen, Michael T. Nurmohamed

    Опубликовано 2022
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice

    Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice по Rabia Agca, Yvo M. Smulders, Michael T. Nurmohamed

    Опубликовано 2021
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Management and evaluation of extra-articular manifestations in spondyloarthritis

    Management and evaluation of extra-articular manifestations in spondyloarthritis по Irene E. van der Horst‐Bruinsma, Michael T. Nurmohamed

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study

    Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study по C. Krieckaert, Michael T. Nurmohamed, Gertjan Wolbink, Willem F. Lems

    Опубликовано 2012
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study

    Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study по Alper M. van Sijl, Maarten Boers, Alexandre E. Voskuyl, Michael T. Nurmohamed

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

    Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment по Ernest Choy, Kandeepan Ganeshalingam, Anne Grete Semb, Zoltán Szekanecz, Michael T. Nurmohamed

    Опубликовано 2014
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  7. 7
    Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion

    Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion по Inge A. M. van den Oever, Alper M. van Sijl, Michael T. Nurmohamed

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

    Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis по Michael T. Nurmohamed, Yanjun Bao, James Signorovitch, Alex Trahey, Parvez Mulani, Diana Dan

    Опубликовано 2015
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus

    Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus по Inge A. M. van den Oever, Hennie G. Raterman, Michael T. Nurmohamed, Suat Şimşek

    Опубликовано 2010
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  10. 10
    Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout

    Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout по Romy Hansildaar, Daisy Vedder, Milad Baniaamam, Anne-Kathrin Tausche, Martijn Gerritsen, Michael T. Nurmohamed

    Опубликовано 2020
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  11. 11
    Is atherosclerosis an autoimmune disease?

    Is atherosclerosis an autoimmune disease? по Eiji Matsuura, Fabiola Atzeni, Piercarlo Sarzi‐Puttini, Maurizio Turiel, Luis R. Lopez, Michael T. Nurmohamed

    Опубликовано 2014
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  12. 12
    (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis

    (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosi... по Debby den Uyl, Michael T. Nurmohamed, L. van Tuyl, Hennie G. Raterman, Willem F. Lems

    Опубликовано 2011
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  13. 13
    The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better

    The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better по Matthew Peters, Alexandre E. Voskuyl, Naveed Sattar, Ben A. C. Dijkmans, Yvo M. Smulders, Michael T. Nurmohamed

    Опубликовано 2010
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial

    Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial по M. l’Ami, C. Krieckaert, Michael T. Nurmohamed, Ronald van Vollenhoven, Theo Rispens, Maarten Boers, Gertjan Wolbink

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review

    Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review по Daisy Vedder, Wendy Walrabenstein, Maaike Heslinga, Ralph de Vries, Michael T. Nurmohamed, Dirkjan van Schaardenburg, Martijn Gerritsen

    Опубликовано 2019
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  16. 16
    Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes

    Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes по Bart Seppen, Simone J. Verkleij, Jimmy Wiegel, Marieke M. ter Wee, Michael T. Nurmohamed, Wouter H Bos

    Опубликовано 2022
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care

    Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care по Markus M. J. Nielen, Alper M. van Sijl, Mike J. Peters, Robert Verheij, François Schellevis, Michael T. Nurmohamed

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.

    Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. по Vokko P. van Halm, Michael T. Nurmohamed, Jos W. R. Twisk, Ben A. C. Dijkmans, Alexandre E. Voskuyl

    Опубликовано 2006
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis

    Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis по J. Christiaan van Denderen, I.M. Visman, Michael T. Nurmohamed, Maria S.A. Suttorp-Schulten, Irene van der Horst‐Bruinsma

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Residual disease activity in psoriatic arthritis: discordance between the rheumatologist’s opinion and minimal disease activity measurement

    Residual disease activity in psoriatic arthritis: discordance between the rheumatologist’s opinion and minimal disease activity measurement по Leonieke van Mens, M. Turina, M. G. H. Van de Sande, Michael T. Nurmohamed, Arno W. R. van Kuijk, Dominique Baeten

    Опубликовано 2017
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: